PRTN3 and rheumatoid arthritis: Currently, several studies have shown an increase in the prevalence of anti-CarP antibodies in RA patients [6, 9–11] and, like ACPA, the presence of anti-CarP antibodies associates with increased joint destruction [6, 9, 10, 12].